Stockwinners Market Radar for February 03, 2022 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:09 EST Cathie Wood's ARK Investment bought 221K shares of Spotify today -

19:03 EST Orchard Therapeutics reaches deal with NHS for pediatric Libmeldy use in MLD - The company states: "Orchard Therapeutics announced it has reached an agreement with the National Health Service that enables access to Libmeldy, or atidarsagene autotemcel, for all children with metachromatic leukodystrophy, or MLD, in England and Wales who fall within the scope of the European marketing authorization. The agreement coincides with publication of the positive National Institute for Health and Care Excellence's final evaluation determination, which recognized the clinical impact and economic benefit of Libmeldy according to the institute's Highly Specialized Technologies process. In addition, the company announced the first two commercially treated patients in Germany and France under reimbursement mechanisms for early access. A third patient from the Middle East was referred for international reimbursed treatment abroad in Italy."

18:14 EST Amazon.com says seeing consistently high renewal rates across geographies - Expects cost pressures to persist in Q1. However, does not see labor and supply chain challenges as great in Q1 compared to Q3 and Q4 of 2021. Says fundamentals of retail business remain strong. Says "feels good" about basic contributors to profitability. Expects CapEx for infrastructure to increase near term. Says evaluates each country differently regarding Prime membership pricing. Comments taken from Q4 earnings conference call.

17:42 EST Nintendo cuts FY22 Switch sales view to 23M units from 24M units - Raises FY22 Switch software sales view to 220M units from 200M units.

17:38 EST Nintendo Switch sales now exceed 100M units - Nintendo said that cumulative hardware sales of the Nintendo Switch has grown beyond 100M units. The total reached 103.54M units, ahead of the total lifetime sales of the Nintendo Wii, which sold 101.63M units. The company added that software unit sales have reached 179.29M units, an increase of 1.8% year-over-year. To date, "Mario Kart 8 Deluxe" is the top-selling game on the platform, with 43.35M units sold, while "Animal Crossing: New Horizons" has sold 37.62M units, "Super Smash Bros. Ultimate" has sold 27.4M units, "The Legend of Zelda: Breath of the Wild" has sold 25.8M units, and "Pokemon Sword/Shield" has sold 23.9M units.

17:28 EST BG Staffing raises quarterly dividend to 15c from 12c per share - The dividend is payable on February 22, 2022 to all shareholders of record as of the close of business on February 14, 2022.

17:25 EST Ford says credit losses 'near record lows' in Q4 - Sees pricing environment to remain strong in 2022. Sees commodity headwinds of $1.5B-$2B. Says anticipating other inflationary pressures at Ford Credit in 2022.

17:16 EST Ford aiming to improve auto EBIT margins - Says began to bring "always-on" vision to life in 2021. Says using hubs to attract more software engineers and technology specialists ahead of electric push. Says customers will be "amazed" as company moves towards central compute strategy. Comments taken from Q4 earnings conference call.

17:10 EST Phillips 66 EVP Herman sells 8,169 common shares - In a regulatory filing, Phillips 66 executive VP Robert A. Herman disclosed the sale of 8,169 common shares of the company on February 2 at a price of $85.8688 per share.

17:00 EST Snap says achieving positive free cash flow for the year an important milestone - Says increasingly able to self fund investments in the future, which positions the company well to accelerate its vision for computing overlaid on the world through augmented reality. Says community grew by 20% year-over-year to 319M daily active users. Says over 200M people engage with augmented reality on Snapchat every day. Says excited by growing demand from businesses who want to bring Snap's AR capabilities into their own apps and websites. Says in Q4, the number of content viewers on Snapchat continued to grow at a significantly faster rate year-over-year than overall time spent watching content. Comments taken from Q4 prepared remarks.

16:57 EST Skechers jumps 10% to $46 after Q4 results beat estimates - The company's Q1 and FY22 revenue guidance also came in ahead of expectations.

16:50 EST NM Water Service gets regulator approval to acquire Hi Mesa Water - California Water Service Group subsidiary New Mexico Water Service received approval yesterday by the New Mexico Public Regulation Commission to acquire the assets of Valencia Mesa, LLC, also known as the Hi Mesa water system, and provide regulated water utility service to its customers in unincorporated Valencia County. The Hi Mesa water system serves about 85 customer connections and is located in Los Lunas, N.M., less than one mile from New Mexico Water's Meadow Lake service area. The transaction, expected to close by the end of 2021, is subject to the completion of conditions in the purchase agreement."We appreciate the diligence by the New Mexico Public Regulation Commission in reviewing this transaction and look forward to working with Valencia Mesa to complete the acquisition," said Group's President and Chief Executive Officer Martin A. Kropelnicki. "We also look forward to serving Hi Mesa water system customers and providing the same quality, service, and value that we are committed to delivering to all of our customers in New Mexico."

16:46 EST Great Elm acquires majority interest in Sterling Commercial Credit for $7.54M - Great Elm Capital announced that it has acquired a majority equity interest in Sterling Commercial Credit a leading asset-based lender. GECC is purchasing a majority ownership position in Sterling for $7.54M, consisting of $4.94M in cash and $2.60M in GECC shares issued at GECC's net asset value. In connection with the transaction, GECC is also providing subordinated debt to Sterling. The majority of the proceeds from the transaction will be retained by Sterling to help support the growth of the business. .

16:42 EST Seacoast Banking announces CEO Charles Shaffer to assume chairman role - Seacoast Banking announced that Charles Shaffer, Seacoast's CEO, will assume the additional position of chairman of Seacoast's board and the company's principal operating subsidiary, Seacoast National Bank, effective February 3. Dennis Hudson, current executive chairman of the board and former chairman of the board and CEO, will continue to serve as a member of the board of the company and the bank, and Christopher Fogal will continue to serve as the board's lead independent director.

16:39 EST Southside Bancshares increases quarterly cash dividend 3% to 34c per share - The board of directors of Southside Bancshares approved a 3% increase to the regular quarterly cash dividend of 1c, to 34c per common share and declared a regular quarterly cash dividend of 34c per common share. The cash dividend of 34c is scheduled for payment on March 3 to common stock shareholders of record on February 17.

16:35 EST Ballantyne Strong acquires land, building in Georgia - Ballantyne Strong announced that it has acquired the land and building at 190 Bluegrass Valley Parkway, in Alpharetta, Georgia, home to its Digital Ignition technology incubator. The 43,000+ square foot building and 11+ acres of land is located approximately 15 minutes north of Atlanta.

16:33 EST Microchip increases quarterly cash dividend to 25.3c per share - Microchip announced that its board of directors declared a quarterly cash dividend on its common stock of 25.3c per share. The dividend is payable on March 8 to stockholders of record on February 22.

16:31 EST GoPro sees slight unit growth, increasing ASPs in FY22 - The company states: "Looking into 2022, we expect slight unit growth and increasing ASPs to drive revenue growth. We are holding our target gross margin range between 40% and 43%, reflecting a continued shift of our hardware ASPs up the price curve, and growth in direct-to- consumer and higher margin subscription revenue. We estimate that new TAM-expanding product introductions, targeted marketing to increase awareness and engagement, and continued conversion of our retail customers, will support growth of our GoPro subscribers by approximately 40% year-over-year to 2.2M. As a reminder, 2.0 million subscribers would translate to annual recurring revenue of $100 million at gross margins of 70-80%. We expect 2022 operating expenses to be in a range of $340M to $350M, with first quarter operating expenses of approximately $80M. We will continue to invest in our direct-to-consumer business, product innovation and targeted marketing, while continuing to drive efficiencies in all areas of our business. We anticipate modest headcount growth for the year."

16:29 EST Arco Platform acquires education solutions from Pearson Education do Brasil - Arco Platform Limited (ARCE) announced that it has acquired in Brazil the following solutions from Pearson Education do Brasil Ltda. (PSO): PGS: a K-12 bilingual courseware and teaching methodology, previously known as Pearson Global School; and Mentes do Amanha: a K-12 supplemental solution focused on 21st century skills. This transaction broadens Arco's supplemental market presence by adding high-quality solutions with pricing complementarity to its portfolio. Arco believes in the large potential for English as a Second Language and in the favorable market trends for 21st century skills. An even stronger portfolio better positions Arco to capture this demand outside and within Arco's school base.

16:27 EST Pinterest up 24% after Q4 results beat expectations - Shares of Pinterest are up $5.77, or 24%, to $30.26 in after-hours trading.

16:25 EST Clorox sees FY22 advertising, sales promotion spending 10% of net sales - The company is confirming the following elements of its fiscal year 2022 outlook: Advertising and sales promotion spending at about 10% of net sales, reflecting the company's ongoing commitment to invest behind its brands. Selling & administrative expenses at about 15% of net sales, reflecting about 1 point of impact from the company's strategic investments in digital capabilities and productivity enhancements. Effective tax rate between 22% and 23%, with the year-over-year increase primarily reflecting the lapping of several one-time benefits in the prior fiscal year.

16:22 EST Snap jumps 40% after earnings report - Shares of Snap are up $9.70, or 40%, to $34.21 in after-hours trading.

16:20 EST Syndax says Michael Metzger to transition to CEO role - Syndax Pharmaceuticals announced that Michael Metzger, President and COO, will transition to the role of CEO, effective Feb. 3. Briggs Morrison, M.D., CEO, will transition to the role of President, Head of Research and Development. Metzger and Dr. Morrison will remain on the company's Board of Directors. Both Metzger and Dr. Morrison joined Syndax together in 2015 with the goal of building a world-class oncology company.

16:20 EST Harmonic authorizes $100M stock repurchase program - Harmonic has authorized a stock repurchase program under which the company may repurchase up to $100M of its outstanding shares of common stock through February 2025. The company intends to fund the share repurchases from cash on hand and cash generated from operations.

16:20 EST Urstadt Biddle Properties Inc. acquires Shelton Square Shopping Center - Urstadt Biddle Properties announced that it has acquired, for $33.6M, Shelton Square Shopping Center, located in Shelton, CT. Shelton Square is a 186,000 square foot community shopping center comprised of one building and three pad sites on a 20+-acre site and anchored by a 67,000 square foot Stop & Shop with a long-term lease. Stop & Shop also leases an additional 70,000 square feet at Shelton Square, which additional space formerly housed a Bradlees department store. Stop & Shop is the former owner of Bradlees, and it has sublet the additional space to Edge Fitness, Hawley Lane Shoes and, previously, Bed, Bath & Beyond. The former BBB space is now vacant and available. In total, Shelton Square is 96.5% leased to a diverse mixture of local, regional, and national tenants. Other tenants include People's United Bank, St. Vincent's/Hartford Health, Burger King, Sports Clips, a local pizzeria, a local wine and spirits store, an optician, a salon, a jeweler, a Chinese restaurant and a brand-new physical therapist.

16:14 EST Mimecast not providing guidance in light of Permira transaction - As announced on December 7, 2021, Mimecast has entered into a transaction agreement whereby funds advised by Permira will acquire all outstanding ordinary shares of Mimecast for $80.00 per share in cash. The transaction remains on track to close in the first half of 2022, subject to customary closing conditions, including approval by Mimecast shareholders and receipt of regulatory approvals. Upon completion of the transaction, Mimecast will become a privately held company and the ordinary shares of Mimecast will no longer be listed on any public market. In light of this transaction, Mimecast will not be hosting an earnings conference call to discuss these results and Mimecast will not be providing guidance for the fourth quarter and fiscal year 2022.

16:13 EST Clorox reports Q2 gross margin down 1240 bps to 33% from 45% a year ago - Driven primarily by higher manufacturing & logistics and commodity costs.

16:12 EST WWE sees FY22 OIBDA of $360M-$375M - In 2022, the Company targets another year of record revenue, with growth driven by the full year impact of ticketed live events , staging of additional large-scale international events, escalation of rights fees for the Company's flagship programs, and monetization of new, original series. Additionally, the Company anticipates a significant increase in its expense base associated with a higher level of activity in the coming year. Accordingly, management has targeted an Adjusted OIBDA range of $360 million - $375 million, an all-time record, as revenue growth is partially offset by the increase in production, content-related and other expenses. In 2022, key initiatives that have meaningful implications for WWE's long-term growth include the licensing of WWE Network in international markets, monetization of new original series, the licensing of Raw second window rights, further progress with sponsorship sales, and the continued execution of WWE's stadium strategy for premium live events. For 2022, the Company estimates total capital expenditures of $280 million - $310 million, including construction spending of approximately $235 million - $255 million. The Company estimates that total capital expenditures related to the new headquarters facility through 2023 will be approximately $270 million - $300 million. The Company expects the total project spend will be partially offset by tenant improvement allowances, tax credits and proceeds from the sale of other real estate assets. The total net cost of the Company's new headquarters through completion, i.e., net of these items, is estimated within a range of $160 million - $180 million. The Company expects total capital expenditures will return to approximately 4% - 5% of revenue once construction of the Company's new headquarters has been completed. These expenditures would be at the low end of the historic range of approximately 4% to 7% of revenue and are predominantly to maintain and enhance existing infrastructure.

16:11 EST Snap reports Q4 DAU up 20% y/y to 319M

16:09 EST Ford sees FY22 adjusted free cash flow $5.5B-$6.5B - Underlying assumptions for 2022 include: Significantly higher profits in North America, along with collective profitability in the rest of the world as the company benefits from its extensive global redesign; Continued variability in supplies of key components, with full-year vehicle wholesales nonetheless being up about 10% to 15%, with a high single- to low double-digit decline in Q1, reflecting supplier shortages related to COVID shutdowns and semiconductors; A strong pricing environment, though with a dynamic relationship between vehicle volumes and pricing; Increased commodity costs, along with possible inflationary effects on a broad range of other expenses' EBT from Ford Credit that remains strong, but lower than in 2021, and; Ongoing investment in the Ford+ plan. "Financial performance is obviously critical," said President and CEO Jim Farley. "We're also proud that customers see how Ford is taking EVs mainstream, and have already ordered or reserved more than 275,000 all-electric Mustang Mach-E SUVs, F-150 Lightning pickups and E-Transit commercial vehicles - and we're breaking constraints to deliver every one of them as fast as we can."

16:08 EST Ford sees FY22 adjusted EBIT $11.5B-$12.5B, up 15%-25%

16:07 EST Amazon CEO continues to feel 'optimistic' despite short-term challenges - Andy Jassy, Amazon CEO, said: "A big thank you to employees across Amazon who overcame another quarter of COVID-related challenges and delivered for customers this holiday season. Given the extraordinary growth we saw in 2020 when customers predominantly stayed home, and the fact that we've continued to grow on top of that in 2021, our Retail teammates have effectively operated in peak mode for almost two years. It's been a tremendous effort, and I'm appreciative and proud of how hard our teams have worked to serve customers. As expected over the holidays, we saw higher costs driven by labor supply shortages and inflationary pressures, and these issues persisted into the first quarter due to Omicron. Despite these short-term challenges, we continue to feel optimistic and excited about the business as we emerge from the pandemic. When you combine how we're staffing and scaling our fulfillment network to bring even faster delivery to more customers, the extraordinary growth of AWS with 40% year-over-year growth (and now a $71 billion revenue run rate), the addition of marquee new entertainment like The Lord of the Rings: The Rings of Power and Thursday Night Football, and a plethora of new capabilities that we're building in areas like Alexa, Ring, Grocery, Pharmacy, Amazon Care, Kuiper, and Zoox, there's a lot to look forward to in the months and years ahead."

16:06 EST Pinterest sees Q1 revenue up in high teens - The company states: "Our current expectation is that Q1 revenue will grow in the high teens percentage range year over year. We expect our non-GAAP operating expenses to grow around 10% quarter-over-quarter in Q1. For the full year, we expect non-GAAP operating expenses to grow around 40% year-over-year as we ramp up our investments in our native content ecosystem, core Pinner experience, and headcount across research and development and sales and marketing. As of February 1, 2021, U.S. MAUs were approximately 86.6M and global MAUs were approximately 436.8M."

16:05 EST Unity Biotechnology initiates restructuring program to focus on ophthalmology - Unity Biotechnology announced it has initiated a restructuring program to align its resources on later-stage programs in ophthalmology while further extending operating capital into Q1 2023. Unity has aligned resources to focus on its clinical programs in ophthalmology and deliver on key development milestones: UBX1325 12-week safety and efficacy data from the Phase 2a DME study by mid-year 2022 as well as 24-week safety and efficacy data from that study before year-end 2022; UBX1325 16-week safety and efficacy data from the Phase 2 wet AMD study before year-end 2022; UBX1325 24-week safety and efficacy data from the additional wet AMD cohort of the Phase 1 study during 1H 2022 and Tie2/VEGF bispecific preclinical data to support selection of advanced candidate by mid-year 2022. Actions to prioritize ophthalmology programs and implement cost saving measures are expected to extend cash runway into Q1 2023, enabling Unity to achieve multiple key clinical data readouts for UBX1325 as well as support the Tie2/VEGF bispecific program through advanced candidate nomination with current cash and cash equivalents. All other pipeline programs will be paused to focus resources on these advanced programs. Unity will reduce its workforce, primarily in Discovery Research, by approximately 50% in order to optimize capital allocation and align with key strategic priorities, reducing its staff to 34 full-time employees by the middle of the year.

16:04 EST SkyWest says block hours may be down 10%-14% in 2022 - The company states: "Given recent staffing challenges, we currently anticipate our block hours in 2022 may be down approximately 10%-15% from our 2021 production."

14:34 EST Manulife Financial does not recommend or endorse Obatan offer for shares - Manulife announced that it has been notified of an unsolicited mini-tender offer made by Obatan LLC to purchase up to 500,000 Manulife common shares, or approximately 0.026% of the common shares outstanding, at a price of $14.40 per share. "Manulife is in no way associated with Obatan and does not recommend or endorse acceptance of this unsolicited offer. Manulife cautions shareholders that the mini-tender offer has been made at a price below the current market price for Manulife shares," the company stated.

14:17 EST AmEx says 'comfortable moving ahead' with widescale return to New York offices - In a memo sent today to all U.S.-based American Express colleagues from Chairman and CEO Stephen Squeri that was shared by the company, Squeri stated in part: "Over the last several weeks, we've been pleased to see that COVID-19 cases in many U.S. locations have been on the decline, particularly in New York City, where we've seen an 75% decrease in new cases from the average two weeks ago. Given the magnitude and rapid pace of this improvement, along with the vaccine requirements and other protocols we have put in place to make our workplace even safer for colleagues, we are now comfortable moving ahead with our widescale return to our New York offices under Amex Flex, starting with a soft launch on Tuesday, March 1 and full implementation on Tuesday, March 15. During the soft launch phase in New York, we are encouraging colleagues in hybrid roles to come into the office at least one day a week. The purpose of this phased approach is to give colleagues some time to adjust to the transition of coming in after working virtually for the past two years, as well as to become familiar with some of the new technology and other changes that have been made to support our new way of working. By March 15, we expect Amex Flex to be in full effect, with colleagues in hybrid roles adopting the schedules set initially with their leaders... It will take a little longer to come back in our other U.S. locations because, while COVID case levels are getting better, the pace of improvement is generally behind what we've seen in New York. As always, we will make decisions to return on a location-by-location basis. We expect to announce dates in other U.S. locations soon and will inform colleagues at least two weeks in advance." Reference Link

12:19 EST Largo announces proposed qualifying transaction for Largo Physical Vanadium - Largo Inc. announced details surrounding Largo Physical Vanadium Corp., currently a holding company, and a proposed qualifying transaction pursuant to the policies of the TSX Venture Exchange with Column Capital Corp, a capital pool company, the terms of which are set out in a non-binding letter of intent dated February 1, 2022. Upon completion of the proposed qualifying transaction and associated regulatory approvals and subsequent financing, it is anticipated that the resulting entity will be named "Largo Physical Vanadium Corp." and will become a publicly listed physical vanadium holding company that will purchase and hold physical vanadium, amongst other things, for use in Largo's VCHARGE batteries to power the global energy transition. Upon completion of the proposed qualifying transaction, the objective of LPV will be to provide a secure, exchange-traded investment alternative for investors interested in direct investment exposure to vanadium. Vanadium is a new-economy material with a constructive ESG alignment through its use in electrolyte solution in long duration VRFBs. Pursuant to the terms of the LOI, LPV and the CPC will negotiate in respect of a definitive agreement and other transaction documentation, incorporating the principal terms of the LOI. Upon completion of the proposed qualifying transaction, the CPC will have acquired 100% ownership of LPV and the business of LPV will become the business of the entity resulting from the proposed qualifying transaction. The final structure for the proposed qualifying transaction is subject to satisfactory tax, corporate and securities law advice on the part of both LPV and the CPC. There is no assurance that the proposed qualifying transaction will be consummated or will be consummated on the terms set out in the LOI.

12:01 EST Snap falls -20.5% - Snap is down -20.5%, or -$6.58 to $25.48.

12:00 EST System1 rises 19.2% - System1 is up 19.2%, or $1.99 to $12.33.

12:00 EST Texas Instruments: Revenue on TI.com for 2021 grew 7x over 2020

11:59 EST Texas Instruments sees RFAB2 production beginning in 2H22, at LFAB in early 2023

11:32 EST LiveOne says 15 claims in Barry Regenstein lawsuit thrown out - LiveOne announced that it had all 15 claims for monetary relief asserted by Barry Regenstein vs LiveOne thrown out in court. LiveOne has filed a motion to have his counsel sanctioned and to pay LiveOne's legal fees incurred in connection with defending the first and fourth causes of action. LiveOne and Robert Ellin are represented by Jeffrey Katz of the Orange County firm of Kesher Law Group. Katz said, "Prior to each motion, Plaintiff and his counsel (Ethan Brown and James Warren of the Brentwood firm of Brown, Neri Smith & Khan) were provided with legal authority demonstrating that the claims lacked merit. They were given the opportunity to withdraw the claims; however, each time, Regenstein and his counsel were recalcitrant." The Brown Neri law firm has lost 8 consecutive motions to Katz and LiveOne spanning across two meritless lawsuits, Barry Regenstein vs LiveOne and Schuyler Hoversten vs LiveOne.

11:12 EST Vistas Media Acquisition Company Inc (Class A Stock) trading resumes

11:02 EST Vistas Media Acquisition Company Inc (Class A Stock) trading halted, volatility trading pause

10:54 EST Redwire: No material misstatements identified in financial statements - As previously announced, Redwire management was notified on November 5, 2021 by an employee of potential accounting issues at a business subunit. Management promptly informed the company's independent Audit Committee of the Board of Directors, its independent registered accounting firm and the SEC. The Audit Committee also promptly engaged independent, external legal and accounting firms to complete an independent investigation. The Audit Committee and Board of Directors have received a preliminary briefing from the independent investigation. To date, there have been no material misstatements identified in the company's previously filed financial statements. Redwire is working to finalize its third quarter 2021 Form 10-Q.

10:41 EST Playtika down 5% after short-seller publishes report

10:16 EST Ek sees 'a lot of opportunity over time' to raise prices 'when it makes sense' - Spotify CEO Daniel Ek said the company will be careful with price increases, but he sees a "lot of opportunity" over time to raise prices "when it makes sense. " Ek made the comments in an interview on CNBC.

10:11 EST Magnolia Oil & Gas declares 20c per share semi-annual cash dividend - Magnolia Oil & Gas announced that its board declared the final semi-annual cash dividend of 20c per share of class A common stock, and a cash distribution of 20c per class B unit payable on March 1, to shareholders of record as of February 14. "We believe our first semi-annual dividend installment of $0.08 per share paid last September to be secure and sustainable with oil prices at less than half their current levels. The final dividend payment of $0.20 per share is based on our actual full-year 2021 financial results, recast using $55 for oil and $2.75 for natural gas, and which approximates our long-term view of product prices. The dividend was included as part of Magnolia's total cash return to shareholders and done in an environment where we also reduced our fully diluted share count by 10 percent and completed some small bolt-on, accretive oil and gas property acquisitions," Magnolia said in a statement.

10:09 EST FDA sends drug safety communication on TG Therapeutics' Ukoniq - The FDA has issued a drug safety communication dated February 3 that states: "The U.S. Food and Drug Administration is investigating a possible increased risk of death with the cancer medicine Ukoniq, umbralisib, approved to treat two specific types of lymphomas, which are cancers that affect the body's immune system. We determined that initial findings from a clinical trial evaluating Ukoniq to treat a related type of cancer found a possible increased risk of death in patients taking the medicine. Because of the seriousness of this safety concern and the similarities between the two types of cancer for which this drug is approved and the type of cancer that was studied in the clinical trial, we are alerting patients and health care professionals that we are re-evaluating this risk against the benefits of Ukoniq for its approved uses. We are continuing to evaluate the results from the clinical trial called UNITY. FDA may also hold a future public meeting to discuss these findings and explore the continued marketing of Ukoniq. We have also suspended enrollment of new patients in other ongoing clinical trials of Ukoniq while we continue to review the UNITY findings. We will communicate our final conclusions and recommendations when we have completed our review or have more information to share." Previously, on January 27, TG Therapeutics disclosed that during a webcast fireside chat with B. Riley, its CEO Michael Weiss shared a data and regulatory update during which Weiss noted that the FDA imposed a partial clinical hold on select studies of U2 and its components for chronic lymphocytic leukemia and non-Hodgkin's lymphoma. Reference Link

10:06 EST GreenLight Bioscences begins trading on Nasdaq - GreenLight Biosciences and Environmental Impact Acquisition Corp. (ENVI), a special purpose acquisition company, yesterday announced the closing of their previously announced business combination. In connection with the closing, the company changed its name to GreenLight Biosciences Holdings, public-benefit corporation, with shares of Class A common stock and public warrants trading today on Nasdaq under the ticker symbols "GRNA" and "GRNA.WS" respectively. The business combination was approved at a special meeting of ENVI stockholders on February 1, 2022.

10:05 EST JLL appoints Christian Whitaker as global head of sustainable operations - JLL (JLL) announced the appointment of Christian Whitaker to Global Head of Sustainable Operations, where he will lead the Energy and Sustainability Services organization, managing JLL's portfolio-wide sustainability programs for the company's investor and corporate clients. The new role reflects the company's ongoing strategy to provide a unified sustainability offering worldwide that helps clients rapidly decarbonize and reach their environmental goals. Whitaker is based in the Washington DC-Baltimore area and for the last 10 years, he served in various leadership roles at Siemens' Building Technologies (SIEGY) and Smart Infrastructure operating companies, most recently as the Global Head of Energy Services.

10:02 EST BAE Systems achieves production milestones for F-35 aircraft - BAE Systems (BAESY) recently delivered its 3,000th vehicle management computer, VMC, and 1,000th active inceptor system, AIS, to Lockheed Martin (LMT) for the F-35 Lightning II aircraft, achieving two production milestones on the platform. "At BAE Systems, we are dedicated to supporting our warfighters with the most advanced systems and technologies," said Ehtisham Siddiqui, vice president and general manager of Controls and Avionics Solutions at BAE Systems. "These two milestones underscore our partnership with Lockheed Martin to consistently deliver proven flight-critical and mission-critical systems on time for the F-35 aircraft." BAE Systems has also reached full-rate production at a level of 19 shipsets per month for its active inceptors.

10:00 EST Clarivate falls -14.5% - Clarivate is down -14.5%, or -$2.57 to $15.14.

10:00 EST Resolute Forest falls -19.9% - Resolute Forest is down -19.9%, or -$2.83 to $11.39.

10:00 EST Lightning eMotors rises 16.3% - Lightning eMotors is up 16.3%, or 71c to $5.06.

09:47 EST Clarivate falls -12.5% - Clarivate is down -12.5%, or -$2.21 to $15.49.

09:47 EST Snap falls -17.9% - Snap is down -17.9%, or -$5.73 to $26.34.

09:47 EST Lightning eMotors rises 11.5% - Lightning eMotors is up 11.5%, or 50c to $4.85.

09:46 EST Air Products raises quarterly dividend 8% to $1.62 from $1.50 per share - This marks the 40th consecutive year that Air Products has increased its dividend payment. The dividend is payable on May 9 to shareholders of record at the close of business on April 1.

09:44 EST Medicare to cover over-the-counter COVID-19 tests in early spring - The Centers for Medicare and Medicaid Services announced that people in either Original Medicare or Medicare Advantage will be able to get over-the-counter COVID-19 tests at no cost starting in early spring. Under the new initiative, Medicare beneficiaries will be able to access up to eight over-the-counter COVID-19 tests per month for free. Tests will be available through eligible pharmacies and other participating entities. The policy will apply to COVID-19 over-the-counter tests approved or authorized by the Food and Drug Administration. Abbott Laboratories (ABT) makes the BinaxNOW over-the-counter test. Reference Link

09:40 EST Honeywell expects 'slow' 1H22 - Says supply chain situation a complete unknown. Says has great projects that will generate returns for investors. Says will continue to make share repurchases when the opportunity arises. Says shares "severely undervalued" now.

09:36 EST Dr. Reddy's to acquire Nimbus Heath, terms not disclosed - Dr. Reddy's Laboratories announced that it has entered into a definitive agreement to acquire Nimbus Health GmbH. Nimbus Health is a privately owned, licensed pharmaceutical wholesaler from Germany focusing on medical cannabis in Germany. Dr. Reddy's will acquire Nimbus Health for an upfront payment plus performance and milestone-based earn-outs over the next four years The company said, "Founded in 2018, Nimbus Health is one of the pioneer companies for medical cannabis in Germany. The acquisition will allow Dr. Reddy's to build on Nimbus Health's strengths and introduce medical cannabis-based medicines as a promising treatment option for patients. The company will be operating under the brand Nimbus Health and as a wholly-owned subsidiary of Dr. Reddy's." The closing of the transaction is subject to customary closing conditions.

09:34 EST Ralph Lauren sees FY revenue roughly in line with pre-pandemic levels

09:33 EST L3Harris selected by U.S. Space Force for space domain awareness - L3Harris Technologies has been selected by the U.S. Space Force to continue efforts to upgrade and modernize its space domain awareness, which is used to help combat anti-satellite threats. The U.S. Air Force began work in 2018 to replace the Space Defense Operations Center with the Advanced Tracking and Launch Analysis System. L3Harris has been developing applications in a new architecture that will allow ATLAS to scale and handle the exponential growth of commercial constellations, increased debris, anti-satellite tests and adversarial threats. Now, L3Harris has been selected to integrate the government's equipment and oversee ATLAS application deployment.

09:31 EST SurModics trading halted, volatility trading pause

09:31 EST Lucira Health commits 2 million at-home COVID-19 test kits on Amazon - Lucira Health announced more than two million Lucira Check-It COVID-19 tests, a rapid at-home test with PCR-quality accuracy, are available on Amazon.com. Lucira's tests are available with 1-2 day Prime delivery nationwide. Lucira's tests are amplification tests, meaning they amplify virus genetic material, just like PCR tests, but are miniaturized to fit in the palm of your hand and were shown to be 98% accurate in a head-to-head comparison to one of the most sensitive lab-based PCR tests. Results are available in 30 minutes with no prescription required. Lucira Check-It tests are also eligible for the recently announced at-home test reimbursement from private insurers. The test kit, the first and only single-use at-home amplification test authorized for emergency use by FDA, is available over the counter. Immediately after testing, users can access a free, text-based digital LUCI PASS verified test result on their phone. The Check-It COVID-19 test kit costs $75 for a single test.

09:14 EST Ralph Lauren: Global operating environment 'highly dynamic'

09:11 EST KeyCorp enters cloud-first partnership with Google Cloud, Deloitte - KeyCorp's (KEY) KeyBank, Google (GOOG) Cloud and Deloitte announced an expanded, multi-year strategic partnership to accelerate KeyBank's commitment to cloud-first banking. KeyBank will operate its primary platforms and applications on Google Cloud infrastructure. KeyBank will use Google Cloud's conversational AI virtual agent, Contact Center AI, to provide more interactions to solve client needs. As KeyBank's systems integrator, Deloitte will help facilitate and optimize KeyBank's migration from data centers to Google Cloud. Under the agreement, KeyBank will migrate its infrastructure to Google Cloud beginning this year and will eventually move the majority of its products and services to the cloud by 2025.

09:10 EST AmpliTech Group receives $2M in new purchase orders in January - AmpliTech Group announced that it has received $2M in new purchase orders during the month of January. The company said this is a record for AmpliTech. These new sales add to what is already a record backlog for AmpliTech. Approximately $1.4M of the new orders represents new customer wins as well as follow-on orders for AmpliTech's industry-leading Low Noise signal Amplifier technology. The new purchase orders also include approximately $0.6M in orders from the Company's Spectrum Semiconductor Materials business acquired in December 2021. Fawad Maqbool, CEO, commented, "AmpliTech's strong start to 2022 substantiates the need for the high levels of performance delivered by our industry-leading LNA technology. Our imminent move to a newly expanded HQ facility on Long Island will enable us to fulfill these orders with greater efficiency and expand our product offering... We are focused on driving increasing order activity for our current product offerings over the balance of the year and also anticipate initial MMIC chip orders later this year from our AGMDC division".

09:09 EST Fortinet announces FortiGate 3000F firewall - Fortinet announced the FortiGate 3000F, the latest Next-Generation Firewall powered by Fortinet's purpose-built NP7 and CP9 security processing units to support organizations in building hybrid IT architectures that accelerate digital innovation and fuel business growth. With built-in network and security convergence, dynamic network segmentation, automation, and natively integrated Zero Trust Network Access capabilities, FortiGate 3000F enables ultra-scalable, security-driven networks that seamlessly converge networking and security without compromising security performance. FortiGate 3000F also offers the highest performance figures in the industry with Security Compute Ratings of up to 6x greater connections per second than competitive offerings.

09:07 EST CleanSpark announces 305 bitcoin produced in January - CleanSpark released its unaudited bitcoin production and operations update for the calendar year-to-date ending January 31, 2022. Bitcoin Production & Operations Update: January monthly production: 305; Total BTC holdings as of January 31: 471; Total BTC converted for operations and growth in January: 467; Currently deployed fleet of approximately 20,500 latest-generation bitcoin miners with a total hashrate of 2.1 EH/s; The Company fully funded growth and operations through the sale of 467 bitcoins in January 2022 at an average of approximately $41,000 per BTC. January daily BTC production reached a high of 10.4.

09:07 EST Rigetti Computing appoints Peter Pace as chairman of the board - Rigetti Holdings announced that it has elected retired Marine General Peter Pace as Chairman of the Board. General Pace, who has served on Rigetti's Board of Directors since June 2017, brings vast leadership expertise gained through his decades-long military career and previous experience serving on the board of directors of several private and public companies. General Pace served as the 16th Chairman of the Joint Chiefs of Staff from 2005 to 2007, the first Marine to hold this position. Rigetti announced in October 2021 that it had entered into an agreement and plan to merge with Supernova Partners Acquisition Company II.

09:06 EST Kiromic BioPharma Pietro Bersani appointed interim CEO - Kiromic BioPharma announces changes in management, and in the Company's Board of Directors. In addition, the Company announces the formation of a Disclosure Committee. Effective January 27, Pietro Bersani, Kiromic's former Chair of the Audit Committee, was appointed as Interim Chief Executive Officer to succeed Dr. Maurizio Chiriva who departed from his roles as Chief Executive Officer and Chairman of the Company's Board of Directors as of that date. Effective January 27 , Company Director Michael Nagel was appointed as the Company's new Chairman of the Board.

09:05 EST Momentive urges shareholders to vote for all proposals on Zendesk transaction - Momentive Global (MNTV) announced that it has filed an investor presentation with the Securities and Exchange Commission, which outlines "the deep strategic rationale and significant opportunities to deliver compelling value" for stockholders through its proposed transaction with Zendesk (ZEN). The presentation can also be found on the Company's investor relations website. Momentive also mailed a letter to stockholders in connection with the upcoming Special Meeting of Stockholders, which has been called to approve the Company's combination with Zendesk. The Momentive Board of Directors continues to unanimously recommend that Momentive stockholders vote on the WHITE proxy card "FOR" all proposals relating to the proposed transaction with Zendesk ahead of the Special Meeting, which has been scheduled for February 25, 2022. The letter read, in part, " At Momentive's Special Meeting of Stockholders, which is scheduled to be held on February 25th, you will have the opportunity to vote on Momentive's transaction with Zendesk. The Momentive Board of Directors is confident that the combination with Zendesk provides significant value for Momentive stockholders given the meaningful opportunities for increased growth and profitability as part of a combined organization. The Momentive Board unanimously recommends that stockholders vote on the WHITE proxy card "FOR" all proposals relating to the proposed transaction with Zendesk today. Together, Zendesk and Momentive will address a larger market with a more differentiated offering. The combined company will deliver higher revenue growth at a significantly larger revenue scale with greater profitability. The result: compelling value and upside participation for Momentive stockholders, who will own approximately 22% of the combined company...Combining with Zendesk delivers significant value for our stockholders through greater scale, faster growth, and increased profitability. The transaction will deliver many compelling financial benefits that Momentive would otherwise not be able to achieve on its own. The Momentive Board unanimously recommends that Momentive stockholders vote in favor of the transaction with Zendesk."

09:04 EST DoorDash, Shake Shack partner on dating site - DoorDash (DASH) and Shake Shack (SHAK) announce "Eat Cute," a limited-time dating site for Shake Shack's Buffalo Chicken Sandwich lovers. Beginning Feb. 3, singles looking to find their sandwich-loving better half can visit LetsEatCute.com to develop their dating profile in less time than it takes to order Shake Shack on DoorDash. This quirky dating site empowers singles to break the ice and spice up their love life, all while bonding over their love for Shake Shack's newly-released Buffalo Chicken Sandwich. Simply upload a selfie, tell us how spicy you like it, and let your passion rage fearlessly for Shake Shack on DoorDash. Instantaneously begin tapping on the flame icon to find your perfect match, then the rest is history - just like that last fry at the bottom of the bag.

09:02 EST Ralph Lauren: Significant reset work 'behind us' - Comments taken from Q3 earnings conference call.

09:02 EST Tarsus Pharmaceuticals appoints Trevejo as Chief Medical Officer - Tarsus Pharmaceuticals (TARS) announced the appointment of Jose Trevejo, M.D., Ph.D., as Chief Medical Officer. Dr. Trevejo brings over 20 years of experience advancing the clinical development of novel therapeutics for serious diseases. Before joining Tarsus, Dr. Trevejo served as Chief Development Officer at Rocket Pharmaceuticals (RCKT)and as CEO of a gene therapy company, SmartPharm.

08:51 EST CMS releases 2023 Medicare Advantage, Part D advance notice - On Wednesday, the Centers for Medicare & Medicaid Services released proposed payment policy changes for Medicare Advantage and Part D drug programs in 2023 "that will create more choices and provide affordable options for consumers that meet their unique health needs." The Calendar Year 2023 Advance Notice for Medicare Advantage and Part D plans is open to public comment for 30 days. This year, CMS is specifically soliciting input through a health equity lens on the approach to some future potential changes. CMS is requesting input on a potential change to the MA and Part D Star Ratings that would take into account how well each plan advances health equity. CMS is also requesting comment on including a quality measure in MA and Part D Star Ratings that would specifically assess how often plans are screening for common health-related social needs, such as food insecurity, housing insecurity, and transportation problems. Other areas that CMS is soliciting input on include a variety of payment updates; a new measure concept to assess whether and how MA plans are transforming care by engaging in value-based models with providers; and updates to risk adjustment models to continue to pay appropriately for the people enrolled in MA and Part D plans. Publicly traded companies in the space include Anthem (ANTM), CVS Health (CVS), Centene (CNC), Cigna (CI), Health Net (HNT), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG).

08:39 EST Strong/MDI, IMAX produce tallest IMAX screen in the world - STRONG/MDI Screen Systems, a wholly-owned subsidiary of Ballantyne Strong (BTN), announced that it has produced and delivered the world's tallest IMAX (IMAX) screen to Royal Cinemas in Pooler, Georgia. The venue is set to open by the end of February 2022. At 76 feet and 2 inches tall, the screen will be used in a custom-built 363-seat auditorium and feature IMAX with Laser technology, a groundbreaking 4k laser projection system that adds a new optical engine, custom designed lenses, and a suite of proprietary technology that delivers brighter images with increased resolution, deeper contrast, and the widest range of colors exclusively to IMAX screens in addition to IMAX precision audio.

08:38 EST IDT Corp says BOSS Money expands money transfer service in Africa - IDT Corporation announced that BOSS Money has expanded its money transfer service in Africa, enabling its US customers to affordably and conveniently send money to Togo and Sierra Leone and adding new payout options in Benin. In Togo, cash can be picked up at over 318 branches of La Poste and Banque Populaire pour l'Epargne et le Credit. In Sierra Leone, cash can be picked up at select Afro International, BnB Transfer and Jalloh Enterprise Ltd., stores. In Benin, cash can now be picked up at La Poste du Benin in addition to Express Union Benin SA branches. BOSS Money customers can also send cash directly to MTN Benin mobile wallets. BOSS Money is also expanding its partnership with the United Bank for Africa. US customers will soon be able to send cash for direct deposit or pick-up at UBA branch offices in Liberia and Ghana. In Nigeria, where BOSS Money currently offers cash pick-up at UBA branches, BOSS Money will soon provide direct deposit to UBA accounts. BOSS Money now offers its US customers transfers to 22 African countries via 126 payers with cash pick-up or deposit available at over 215,000 locations.

08:36 EST Opko Health says RAYALDEE launched in Germany by VFMCRP - OPKO Health (OPK) announces that Vifor Fresenius Medical Care Renal Pharma (GNHAF, FMS) has initiated the commercial launch of RAYALDEE in Germany, the first launch of RAYALDEE outside the U.S. VFMCRP is OPKO's commercial partner for RAYALDEE in Europe and selected markets outside the U.S., and the sales kick-off in Germany began with presentations by VFMCRP executives and several nephrology key opinion leaders. RAYALDEE extended-release capsules are indicated for the treatment of secondary hyperparathyroidism in adult patients with stage 3 or 4 chronic kidney disease and vitamin D insufficiency. VFMCRP has received marketing authorizations for RAYALDEE in 11 European countries and expects to launch in additional markets later this year.

08:34 EST BK Technologies announces amended contract with DoE utility agency - BK Technologies announced that its original contract with an electric utility agency of the U.S. Department of Energy, or DoE, signed in August 2020, has been amended to increase its ceiling from $4.2M to $7M. By the terms of the agreement, BK will continue to provide its KNG2 and KNG Digital P-25 portable and mobile radios with related accessories, to be deployed at more than 35 sites in the U.S. The amended one-year contract was effective as of June 2021 and expires in June 2022, providing for purchases of equipment up to $7M and includes two additional one-year extension options. It does not specify precise delivery dates or quantities. Shortly after awarding the contract, the DoE issued a purchase order for KNG-Series Mobile Radios totaling $50,000.

08:32 EST Tesla recalls over 800,000 vehicles for seat belt chime issue - Tesla is recalling more than 817,000 vehicles in the U.S. because the seat belt reminder chimes may not sound when the vehicles are started and the driver hasn't buckled up. The recall covers the 2021 and 2022 Model S sedan and Model X SUV, as well as the 2017 through 2022 Model 3 sedan and 2020 through 2022 Model Y SUV, according to documents posted by the NHTSA. As of January 31, Tesla said it is not aware of any warranty claims, field reports, crashes, injuries or fatalities related to the condition.

08:32 EST MGM Resorts, BetMGM and the NHL extend partnership - MGM Resorts, BetMGM, a sports betting and digital gaming operator, and the National Hockey League, or NHL, announced a multi-year extension of their partnership. MGM Resorts, which operates T-Mobile Arena, prepares to host Honda NHL All-Star Weekend festivities in Las Vegas Feb. 4-5. Several special events will take place at MGM Resorts' properties along the Las Vegas Strip as well. BetMGM and MGM Resorts will continue to be integrated into the NHL's jewel events, with camera-visible signage and on-site activation opportunities. Additionally, BetMGM and MGM Resorts will maintain the ability to reach hockey fans through communications to subscribers from the NHL's fan database. MGM Resorts became the NHL's first official sports betting partner in 2018.

08:30 EST Hall of Fame Resort & Entertainment announces partnership with Allied Sports - Hall of Fame Resort & Entertainment announced it has selected Allied Sports as its agency of record for all sponsorship and media opportunities. "We are thrilled to partner with HOFV at such an exciting time for the multi-dimensional sports and entertainment company," said Greg Luckman, Chief Executive Officer of Allied Sports. "HOFV's unique offering of destination, media and gaming experiences offers limitless potential for brands looking to leverage the power of professional football across multiple platforms."

08:23 EST Charles River Laboratories in wind contract with Repsol for Europe operations - Charles River Laboratories International (CRL) announced a wind energy contract with Repsol (REPYY) to address the entirety of the Company's European power requirements with renewable energy by 2023.Wind turbine at a Repsol wind farm. Charles River has entered into a virtual power purchase agreement with Repsol, a multi-energy company, for wind energy in Spain. The contract is for 30.5 megawatts of renewable energy, which is equivalent to avoiding carbon emissions from the annual electricity consumption of more than 28,000 homes. The VPPA is associated with a wind farm that is part of Repsol's Delta II project. Repsol continues to promote its low carbon generation business through the development of quality and profitable renewable assets. The project has already begun construction and, once completed in 2023, will have a total capacity of 860 MW distributed among 26 wind farms located in the Spanish region of Aragon. Renewable power generation is one of the pillars of Repsol's decarbonization strategy. As a result, Repsol recently raised its installed capacity targets for 2030 to 20 gigawatts , an increase of 60% over the previous target. By 2025, installed capacity will increase to 6 GW.

08:21 EST BioCardia granted breakthrough therapy device designation for CardiAMP - BioCardia announced that the FDA has granted breakthrough device designation for the CardiAMP Cell Therapy System for the treatment of heart failure. It is believed to be the first cardiac cell therapy to receive FDA Breakthrough Device status.

08:20 EST Old National Bancorp announces $8.3B community benefits agreement - Old National Bancorp announced a $8.3B Community Growth Plan that "builds on its long-standing commitment to support historically underserved and economically disadvantaged individuals, families and communities throughout its footprint," the company said. The Plan was developed in collaboration with the National Community Reinvestment Coalition, NCRC, and its members and is subject to the closing of the First Midwest merger. The Plan includes nearly $5B in community lending and affordable housing commitments to underserved and low-to-moderate income borrowers and another $3.3B in community development initiatives and philanthropic programs in LMI and majority-minority neighborhoods over a five-year period. These investments include communities already served by Old National, as well as communities it will serve after completion of the merger with First Midwest. "At Old National and First Midwest, engaging with, supporting and strengthening our communities is not only a strategic priority, it's woven into the fabric of our cultural DNA," said Old National Chairman and CEO Jim Ryan. "We recognize the important role that our banks play in helping to shape a better financial future, and we are proud to partner with NCRC to build on our strong legacy of service and make a lasting impact on the hundreds of communities we serve today, as well as in the future."

08:18 EST Global Blood Therapeutics announces employment inducement grants - Global Blood Therapeutics announced that on February 1, 2022, the compensation committee of GBT's board of directors granted 21 new employees options to purchase an aggregate of 33,290 shares of the company's common stock with a per share exercise price of $29.33 and restricted stock units for an aggregate of 80,100 shares of the company's common stock. These awards were made under GBT's Amended and Restated 2017 Inducement Equity Plan. The above-described awards were each granted as an inducement material to the employees entering into employment with the company in accordance with NASDAQ Listing Rule 5635(c)(4), and were granted pursuant to the terms of the Plan. The Plan was adopted by GBT's board of directors in January 2017 and has been amended and restated from time to time.

08:17 EST AFC Gamma appoints Marnie Sudnow to board of directors - AFC Gamma announced the nomination and appointment of Marnie Sudnow to AFC Gamma's Board of Directors. In connection with the appointment of Mrs. Sudnow, the Board was expanded to eight directors, six of whom are independent. Since 2020, Marnie Sudnow has served as the Senior Vice President of Client Success at Stylitics.

08:16 EST Acuity Brands announces new initiative planned to reduce paper waste - Acuity Brands announced a new initiative planned to reduce paper use by more than 15M sheets and save an estimated 1,500 trees per year through its introduction of scannable QR code instructions. "Our products last for years and sometimes decades, and over time, the paper installation instructions are discarded or misplaced. Giving our customers digital access to the documents they need helps minimize waste and makes our product information more accessible," said Trevor Palmer, President, Acuity Brands Lighting and Lighting Controls. The introduction of digital QR code installation instructions is expected to reduce the Company's CO2 emissions by approximately 423,000 pounds per year. Acuity plans to make QR code instructions available for several top-selling products in its portfolio starting in May 2022.

08:15 EST LMP signs $29M agreement to acquire property for CDJR dealership relocation - LMP Automotive announced it has agreed to acquire an 84,000 sq. ft. property on a 161,000 sq. ft. site for $29M for its White Plains, N.Y. CDJR dealership relocation and expansion. Richard Aldahan, LMP's Chief Operating Officer, stated, "This is a trophy property located in one of the best and highest trafficked areas in Westchester County. The property provides for a significant modernized expansion to service bays, showroom, and added parking for hundreds of additional vehicles which creates one of the largest and most profitable CDJR dealerships in the New York region. We expect to be operational in the new site by the fourth quarter of this year."

08:13 EST Shyft Group board increases quarterly dividend to 5c from 2.5c - The Shyft Group announced that its Board of Directors has authorized an increase in the Company's common stock from 2.5c to 5c per share. The Michigan-based manufacturer reported that its quarterly dividend will be payable on or before March 17, 2022, to shareholders of record at the close of business on February 17, 2022. "We are pleased to announce an increase in our quarterly cash dividend, which is a 100% increase over the previous quarterly amount," said Daryl Adams, President and Chief Executive Officer. "The dividend increase reflects the Board's confidence in the Company's financial strength and market outlook and demonstrates our continued commitment to returning capital to shareholders."

08:12 EST Achieve Life Sciences announces expansion of clinical operations team - Achieve Life Sciences announced that the Company has expanded its Clinical Operations Team with the hiring of a Director of Clinical Operations. Achieve's Board of Directors approved the new employment inducement grant of stock options to purchase 15,000 shares of Achieve's common stock with a grant date of January 31, 2022.

08:11 EST Edgewell Personal Care appoints LaTanya Langley as Chief Legal Officer - Edgewell Personal appointed LaTanya Langley as Chief Legal Officer effective February 28. Langley will be based in the company's Shelton, Connecticut office. Langley joins Edgewell from BIC Corp. where she served as Vice President, General Counsel and Corporate Secretary. Prior to that, she previously held positions of increasing responsibility within the legal function at BIC(R), both in the United States and internationally. Prior to joining BIC(R), Langley held several legal positions at Diageo.

08:10 EST Cerberus Cyber names Sanchez president of the company - Cerberus Cyber Sentinel announces that Rory Sanchez has been named president of the company. He will be responsible for mergers and acquisitions and work closely with CEO David Jemmett and CFO Deb Smith. Previously, Sanchez served as CEO of True Digital Security, a cybersecurity operations and compliance company.

08:09 EST BIO-key signs definitive agreement to acquire Swivel Secure Europe - BIO-key International announced that it has signed a definitive agreement to acquire Swivel Secure Europe, SSE, a privately-held IAM solutions provider based in Spain. The transaction is expected to close in February and be accretive to BIO-key's earnings, excluding one-time acquisition-related costs and ongoing purchase accounting amortization expenses. As a result of the acquisition, BIO-key will add a sales and support team with customer and industry contacts throughout the EMEA region. Alex Rocha, SSE's sole stockholder and Chief Executive Officer, will also assume responsibility for EMEA operations reporting directly to BIO-key's Chairman & CEO. "Swivel Secure Europe and its talented team have established a deep network of partners and customers across Europe, the Middle East and Africa, and this acquisition significantly strengthens BIO-key's presence in those regions," said BIO-key Chairman & CEO Michael DePasquale. "We are seeing cyber attacks and threats grow in sophistication and scale and as a result, demand for proven IAM solutions continues to grow. We look forward to expanding our global sales footprint and to supporting Swivel Secure Europe's customers and partners through an award-winning and cost-effective portfolio of existing and new IAM and identity-bound biometric solutions."

08:07 EST Pasithea initiates new chemical entity drug development program in MS - Pasithea Therapeutics announced a new chemical entity, NCE, development program and named Massachusetts-based Hooke Laboratories as its research partner. The Company aims to develop a tolerizing vaccine for multiple sclerosis, MS, a potentially disabling autoimmune disease in which the immune system attacks myelin, the protective sheath that surrounds nerves in the brain and spinal cord. Pasithea's Chairman, National Academy of Sciences Professor Lawrence Steinman, will help lead the program. "Our decision to initiate a program in MS is a strong strategic fit and a natural progression of our work and mission," stated Dr. Tiago Reis Marques, Chief Executive Officer of Pasithea Therapeutics. "Prof. Steinman's expertise, along with our capabilities in central nervous system disorders, position us well to develop a new approach for the treatment for MS."

08:06 EST Greenland Technologies, Cyngn announce strategic partnership - Cyngn (CYN) and Greenland Technologies (GTEC) announced they are embarking on a strategic partnership whereby Cyngn will bring its self-driving vehicle capabilities to Greenland forklifts with its proprietary Enterprise Autonomy Suite. Integration of EAS will enable Greenland forklifts to switch easily between fully autonomous, manual, and remotely-controlled modes. Organizations that run Cyngn's autonomous vehicle technology also gain access to a breadth of analytics and software tools to generate operational insights and optimizations.

08:05 EST Marinus Pharmaceuticals announces preliminary results from M2 metabolite study - Marinus Pharmaceuticals announced preliminary results from an in vivo study on the M2 metabolite showing that no genotoxicity was found, as measured by formation of micronuclei in the bone marrow or comet morphology in the liver. Marinus also announced its marketing authorization application, or MAA, for ganaxolone in CDKL5 deficiency disorder will convert to a standard review and that it had reached an agreement with the European Medicines Agency to extend the Day 120 clock stop by three months to allow sufficient time to respond to questions received as part of the review process. The company now expects the EMA's Committee for Medicinal Products for Human Use opinion on the MAA by year end 2022.

08:05 EST Antares Pharma announces FDA acceptance of NDA resubmission for TLANDO - Antares Pharma announced that the U.S. Food and Drug Administration, FDA, has accepted its New Drug Application, NDA, resubmission for TLANDO, an oral treatment for testosterone replacement therapy. The FDA designated the NDA as a Class 1 resubmission with a two-month review goal period and set a target action date of March 28, 2022, under the Prescription Drug User Fee Act, PDUFA. "As we take this final step moving from tentative approval to potential final approval in late March, we will continue to prepare for the commercial launch of TLANDO. Our National Sales Meeting is set for the end of April and will serve as the venue to train and ready our sales professionals to start promoting TLANDO to the medical professionals who treat testosterone deficiency. We are excited to be able to complement our current offering of XYOSTED with an oral formulation to patients and physicians. We will leverage our strong physician relationships which we believe will accelerate the adoption of TLANDO, support our future revenue growth and drive our market share gains in the testosterone market," commented Robert F. Apple, President and Chief Executive Officer of Antares Pharma.

07:57 EST Science 37, physIQ collaborate to enhance trial data from connected devices - Science 37 Holdings announced a collaboration to help research sponsors use remote biosensors and machine learning to build more robust data sets. This will help increase the number of digital biomarkers and generate insights from continuous data streams to more quickly and objectively demonstrate the safety and efficacy of treatments. physIQ's robust platform scalability, near real-time capabilities, established FDA clearance, and proven ability to support large global clinical trials strengthen Science 37's ability to support additional novel digital biomarkers, advance clinical events detection and provide more proactive safety monitoring. physIQ enables Sponsors to efficiently identify valuable digital measures from large amount of noise inherent in biosensors.

07:53 EST Powerbridge enters metaverse space through pact with Beyondvision - Powerbridge announced its partnership between its wholly-owned subsidiary, Powermeta Digital and Beyondvision to jointly establish Metafusion Digital with the vision to embrace metaverse into the virtual world of travel and leisure. Metafusion will apply metaverse and NFT related technologies in an effort to reshape the travel and leisure industry services and elevate consumer experience with digital spaces.

07:51 EST Monarch receives final payment of $3.75M from Gold Royalty - MONARCH MINING CORPORATION is pleased to announce that it has received a final cash payment of $3.75 million from Gold Royalty Corp. in connection with the sale of royalties on the Beacon, Croinor Gold, McKenzie Break and Swanson properties. "These funds will further strengthen our working capital in preparation for the restart of the Beaufor Mine and Beacon Mill expected by June 2022," said Jean-Marc-Lacoste, President and CEO of Monarch.

07:50 EST Sienna Senior Living forms joint venture with Sabra Health Care - Sienna Senior Living Inc. (LWSCF) announced that it has entered into an agreement to acquire a 50% ownership interest in a portfolio of eleven seniors' living assets in Ontario and Saskatchewan consisting of 1,048 high-quality, private-pay suites. Sienna will acquire the Portfolio in partnership with Sabra (SBRA), who is acquiring the other 50% interest, with Sienna as the manager of the Portfolio. Sienna and Sabra will acquire the Portfolio from Extendicare (EXETF), with the Portfolio representing the entirety of Extendicare's currently owned private-pay retirement properties in Canada. The Portfolio is an attractive expansion opportunity for Sienna in its existing Ontario markets, featuring high-quality, recently built retirement residences. It also provides an entry into the Saskatchewan market with immediate scale and a platform for further expansion. Strategically located in growing communities, the properties are well positioned with coveted locations in their respective markets. With an average age of approximately six years, the Portfolio offers modern seniors living accommodation with extensive amenities reflecting the changing lifestyle preferences of seniors. While predominantly consisting of independent living suites, the Portfolio offers opportunities to age in-place with private-pay assisted living and memory care suites. Sienna's share of the purchase price for the Portfolio is $153.75 million. The Company expects the Acquisition to generate an approximate 6% unlevered yield in the first twelve months following closing of the transaction. The newly formed joint venture, with Sienna acting as a manager, is an endorsement of the Company as one of Canada's leading operators of seniors' living properties. The joint venture is expected to become an additional avenue of future growth for the Company, as it collaborates with Sabra on new growth initiatives in Canada. As manager of the Portfolio, Sienna will generate enhanced returns on the Acquisition through a management fee income stream, expanding upon an already established operating relationship and existing revenue stream that Sienna earns as manager of eight Canadian retirement residences which are wholly-owned by Sabra. The Acquisition is expected to be accretive to Sienna's OFFO and AFFO per common share on a leverage neutral basis. The Acquisition and related transaction costs are being financed through a combination of: $150 million acquisition term loan that the Company expects to refinance post-closing; proceeds from the previously announced sale of Rideau Retirement Residence and Camilla Care Community; and draws on the Company's existing credit facilities. Following the closing of the Acquisition, the Company's Debt to Gross Book Value ratio on a pro forma basis, taking into account expected proceeds from the sale of Rideau Retirement Residence and Camilla Care Community, is expected to increase from 46% as at September 30, 2021 to approximately 48%. Completion of the Acquisition is subject to customary closing conditions for transactions of this nature, including the receipt of all necessary regulatory approvals, including approvals from the Ontario Retirement Homes Regulatory Authority and the Saskatchewan Health Authority, and pursuant to the Competition Act. Sienna expects the completion of the Acquisition to occur in late Q2 2022.

07:46 EST Mindset Pharma synthesizes additional candidates from Family 3 compounds - Mindset Pharma announced that it has synthesized additional promising candidates from its Family 3 of next generation drug candidates, and will initiate Proof of Concept preclinical studies to further measure the viability of these compounds as daily pro-cognitive take-home medication. "Our scientists designed and developed a unique class of novel and patentable compounds, our 'Family 3,' which have shown promise as a substitute for microdosing approaches due to their low activity at the 5-HT2A receptor. This validates our decision to study the efficacy of these compounds further for pro-cognitive indications associated with neurological and mental health disorders," said James Lanthier, CEO of Mindset. "If we can demonstrate pro-cognitive benefits at a range of sub-hallucinogenic doses, our compounds have the potential to dramatically broaden the addressable neurology and mental health market we are pursuing while avoiding the hallucinogenic liability associated with traditional approaches. Providing pro-cognitive solutions that do not elicit a psychedelic effect will suit vulnerable patient populations such as juvenile ADHD, Alzheimer's disease, and a range of others." To better understand potential pro-cognitive benefits across a range of sub-hallucinogenic doses, Mindset will initiate a series of in vivo Proof of Concept studies, which will measure motivation and attention. These studies will be critical in establishing the clinical viability of Mindset's family 3 drug candidates. Mindset recently announced a first-of-its-kind co-development agreement with the McQuade Center of Strategic Research and Development, a member of the Otsuka Pharmaceuticals family of companies, which fully funds and advances the development of Mindset's Family 2 & Family 4. Family 3 compounds are potential opportunities for Mindset to partner with other groups to progress its most promising candidates from this family to the clinic.

07:44 EST Calibre Mining outlines results from 2021, key 2022 objectives - Calibre Mining provides an update in respect of the Company's 2022 discovery and resource expansion drilling programs, highlighting results from 2021 and outlining key 2022 targets and objectives. 2021 Highlights and 2022 Objectives: Year end 2020 reserves increased 200% to 864,000 ounces grading 4.49 g/t gold after depletion; 2022 programs have been designed to target greater than250,000-ounce deposits to help bolster the Company's project pipelines; Approved a $22 million exploration budget for 2022. Darren Hall, President & Chief Executive Officer of Calibre, stated: "During 2021 our primary exploration efforts focused on increasing confidence in known resource areas at Limon, Libertad, Pavon and EBP which I expect will positively impact reserves after 2021 depletion and further increase confidence in future production... As a result of the exploration work completed over the last two years, we are in a strong position for 2023 and 2024 production growth. The discovery of new gold zones and continued progress at the high-grade EBP strengthens our outlook to continually expand resources and reserves. Our initial focus at EBP has been to progress the Guapinol, Vancouver and Riscos De Oro deposits which continues with permitting, studies and consultation followed by a construction decision in the first half of 2023. We continue to discover and develop new ore bodies through a sustained commitment to exploration, thereby unlocking the growth and discovery opportunities we see across our portfolio of mines and exploration properties."

07:43 EST Biohaven Pharmaceutical's Nurtec shows migraine reduction in published report - Biohaven Pharmaceutical announced the publication of new findings from its long-term safety study showing reductions in migraine frequency in patients treated with rimegepant 75 mg for the acute treatment of migraine in the February issue of Cephalalgia Reports, a medical-neurological journal in the field of headache research and official journal of the International Headache Society. The published paper describes outcomes from patients treated with rimegepant 75 mg as needed for the acute treatment of migraine, expressed as median time to greater than or equal to 30% and greater than or equal to 50% reduction in monthly migraine days, or MMD. The published data shows that long-term acute treatment of migraine attacks with rimegepant 75 mg lowered monthly disease burden by reducing the number of migraine days. Clinically significant reduction in MMD frequency was observed over time regardless of baseline migraine frequency. Nurtec ODT - rimegepant - was approved by the FDA for the acute treatment of migraine in February 2020 and for the preventive treatment of episodic migraine in May 2021.

07:42 EST Rafael Holdings terminates merger agreement with Rafael Pharmaceuticals - In a regulatory filing last night, Rafael Holdings disclosed that on February 2, the company delivered a letter to Rafael Pharmaceuticals pursuant to which the company terminated their previously announced merger agreement, effective immediately. "As previously disclosed on a current report filed on June 17, 2021, Rafael Holdings entered into an agreement and plan of merger, by and among the company, certain subsidiaries of the company and Rafael Pharmaceuticals, Inc. The merger agreement provided for Pharma to become a wholly-owned subsidiary of the company and for holders of capital stock of Pharma other than the company and its controlled affiliates to receive shares of company Class B common stock in exchange for their interests in Pharma... As of October 31, 2021, based on information available to the company, the company and its subsidiaries held capital stock of Pharma representing 51% of the outstanding capital stock of Pharma and 41% on a fully diluted basis, excluding the remainder of a warrant held by the company to acquire shares of Pharma and other interests held by the company that may be convertible into equity securities of Pharma. The company may seek to enter into discussions with Pharma regarding the relationship between the companies in light of the termination of the merger agreement," the filing stated.

07:40 EST Extendicare to sell Esprit retirement communities for $307.5M - Extendicare (EXETF) announced that it has entered into an agreement to sell its retirement living operations comprised of 1,048 retirement living suites across 11 retirement communities , located in Ontario and Saskatchewan, to Sienna-Sabra LP, a partnership formed between Sienna Senior Living Inc. (LWSCF) and SABRA Healthcare REIT (SBRA), for an aggregate purchase price of $307.5M, subject to customary closing adjustments. Closing of the Transaction is subject to customary closing conditions, including receipt of regulatory approvals from the Ontario Retirement Homes Regulatory Authority and Saskatchewan Health Authority and pursuant to the Competition Act, and is not conditional on financing or due diligence. The Transaction is expected to close in the second quarter of 2022. The Transaction is structured on a debt-free basis, with existing debt associated with the Portfolio of approximately $172.4M, as well as estimated debt prepayment costs of approximately $6.3M, being repaid at closing from Transaction proceeds. The implied realized capitalization rate on stabilized net operating income for the transaction is approximately 6.0%. The estimated net proceeds to be realized on the sale, net of debt repayments, taxes, certain closing adjustments and transactions costs, is estimated to be approximately $115M.

07:38 EST Hut 8 Mining provides production update for January - Hut 8 Mining (HUT) provided a corporate update. 308 Bitcoin (BTC) were mined, resulting in an average production rate of 9.93 Bitcoin per day; approximately 16% of Bitcoin production was from the company's fleet of GPU miners, being used to mine Ethereum, while receiving payouts in Bitcoin. Average cost was less than C$2,600 per Bitcoin. 100% of the self-mined Bitcoin for the month of January were deposited into custody, consistent with Hut 8's Hodl strategy; total Bitcoin balance held in reserve is 5,826 as of January 31, 2022; installed operating capacity currently sits at 2.36 EH/s, a 17% increase from December 31, 2021. During January 2022, the company installed 6,317 MicroBT M30S and M31S+ miners, while retiring the older fleet of Bitfury Clarkes. Hut 8 has also advanced with respect to construction and development of the Company's third data centre located in North Bay, Ontario. Racking is expected to commence later in February.

07:37 EST Iridium names Kathy Morgan as new Chief Legal Officer - Iridium announced that Kathy Morgan has been named its Chief Legal Officer. Morgan assumed this position effective January 1, succeeding former CLO Tom Hickey. Previously, she served as Iridium's Vice President of Corporate Law.

07:35 EST CME Group raises quarterly dividend 11% to $1.00 from 90c per share - The dividend is payable March 25 to shareholders of record as of March 10.

07:29 EST Berry Global announces $1B share repurchase plan - Berry Global announced that its board of directors has authorized a new share repurchase program under which the company may repurchase up to $1B of its outstanding shares of common stock. The company currently expects to repurchase at least $350M of shares outstanding in FY22, including the $50M shares repurchased in the first fiscal quarter, and to fully utilize the program over the next two to three fiscal years.

07:21 EST Tradeweb Markets sees FY22 adjusted expenses $620M -$655M - Tradeweb Markets sees adjusted expenses: $620 - $655M; Acquisition and Refinitiv transaction related depreciation and amortization expense: $127M; Assumed non-GAAP tax rate: 22.0%.

07:21 EST Voyager appoints Sandrock to board of directors, promotes Swartz to COO - Voyager Therapeutics (VYGR) announced the appointment of Alfred Sandrock, Jr., M.D., Ph.D. to its Board of Directors, effective February 7, and a newly formed Executive Committee of the Board consisting of Dr. Sandrock, Michael Higgins, interim chief executive officer and Board Chairman, and Glenn Pierce, M.D., Ph.D., interim chief scientific officer and Board member. The Company also announced the promotion of Robin Swartz to chief operating officer, COO, effective February 7. "Dr. Sandrock joins Voyager following a prolific career in biopharmaceutical drug development. Dr. Sandrock spent 23 years at Biogen (BIIB) where he identified and developed novel therapies for a variety of serious diseases," the company said.

07:19 EST Novavax receives MHRA authorization for Nuvaxovid COVID-19 Vaccine in adults - Novavax announced that the Medicines and Healthcare products Regulatory Agency, or MHRA, has granted conditional marketing authorization for Nuvaxovid COVID-19 Vaccine for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals 18 years of age and older in Great Britain. The vaccine, also known as NVX-CoV2373, is the first protein-based vaccine to be authorized for use in Great Britain.

07:16 EST The Very Good Food Company provides operations update - The Very Good Food Company announced increased retail distribution, inaugural production from its Patterson Facility and upcoming innovations. The company's Very Good Butchers products are now available in 400+ locations in 30 cities across 25 states in the USA, and 1100 locations across Canada. The company began producing Taco Stuffer at its Patterson facility in California in 4Q21 to meet growing sales volume driven by its expanded distribution at retail stores. Very Good has plans to produce Stuffed Beast and other innovative products at Patterson later in 2022 to support the company's North American growth strategy. The company will soon be launching Spicy mmmMeatballs, a spicy iteration of the Mmmmm...Meatballs. Very Good is also introducing two new plant-based ground meats, A Cut Above Pork, and A Cut Above Beef, a new subcategory of refrigerated plant-based meat.

07:13 EST BioCryst reports inducement grants under Nasdaq listing rule - BioCryst Pharmaceuticals announced that the compensation committee of BioCryst's board of directors granted 31 newly-hired employees stock options to purchase an aggregate of 213,500 shares, and restricted stock units covering an aggregate of 24,700 shares, of BioCryst common stock. The options and RSUs were granted as of January 31, 2022 as inducements material to each employee entering into employment with BioCryst. The options and RSUs were granted in accordance with Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $15.45 per share, which is equal to the closing price of BioCryst common stock on the grant date. The options and RSUs vest in four equal annual installments beginning on the one-year anniversary of the grant date, in each case subject to the new employee's continued service with the company. Each stock option has a 10-year term. The options and RSUs are subject to the terms and conditions of BioCryst's Inducement Equity Incentive Plan and a stock option agreement or restricted stock unit agreement, as applicable, covering the grant.

07:11 EST Codorus Valley confirms receipt of Driver's notice to nominate directors - Codorus Valley Bancorp confirmed receipt of notice from Driver Management Company LLC and its affiliates of its intent to nominate three individuals to stand for election to Codorus Valley's Board of Directors at the Corporation's 2022 Annual Meeting of Shareholders. The company said, "The Board will review Driver Management's proposed nominees and present its recommendations in the Corporation's definitive proxy statement, which will be filed with the U.S. Securities and Exchange Commission and mailed to all shareholders eligible to vote at the 2022 Annual Meeting. Codorus Valley shareholders are not required to take any action at this time."

07:10 EST Freight App forms strategic alliance with Zaro Transportation - Hudson Capital announced that Freight App entered into a strategic alliance with Zaro Transportation, the second-ranked company when measured by the number of units as registered with the Mexican Transportation and Communications Secretary. Zaro plans to use Fr8App's artificial intelligence and electronic data interphases technology to facilitate the delivery of truck freight services to US-based accounts.

07:08 EST Stantec awarded five-year $45M IDIQ contract - Stantec has been awarded a five-year indefinite delivery/indefinite quantity contract to provide a full suite of architectural, engineering, professional, and technical services for the Bureau of Reclamation, a federal agency under the U.S. Department of the Interior. Stantec's work will support Reclamation's mission to assist in meeting the increasing water and power demands of the Western US while protecting the environment. In alignment with the US infrastructure bill, which prioritizes water, dam, and hydropower security, Stantec will support a variety of projects, including dams, canals, fish passage, hydropower facilities, hydraulic structures, pipelines, new buildings, bridges, water treatment plants, and additional water infrastructure. Work under this IDIQ contract may be performed throughout Reclamation's footprint, which spans 17 Western States. Under the $45M contract, Stantec will work closely with Reclamation's Technical Services Center-the organization's resource center for engineering, scientific, and technical expertise-on a variety of projects within the civil, geotechnical, mechanical, electrical, water and environmental science, engineering, risk analysis, dam safety, and security professional service areas.

07:06 EST ConocoPhillips FY22 production view 1.75 MMBOED-1.79 MMBOED - The company's 2022 operating plan capital budget is $7.2 billion. The plan includes funding for ongoing development drilling programs, major projects, exploration and appraisal activities, base maintenance and $0.2 billion for projects to reduce the company's Scope 1 and 2 emissions intensity and fund investments in several early-stage low-carbon opportunities that address end-use emissions. The company's 2022 production guidance is 1.8 million barrels of oil equivalent per day including Libya but excluding impacts from the pending Indonesia disposition and acquisition of additional APLNG shareholding interest. First-quarter 2022 production is expected to be 1.75 MMBOED to 1.79 MMBOED, essentially flat to fourth-quarter 2021 on a pro forma basis. Guidance for 2022 includes adjusted operating cost of $7.3 billion reflecting increased production, costs incurred following conversion of previously acquired Concho two-stream contracted volumes to a three-stream basis, and some anticipated inflation; adjusted corporate segment net loss of $1.0 billion; and depreciation, depletion and amortization of $7.9 billion. Guidance excludes potential special items.

07:05 EST Pardes Biosciences announces FDA clearance of IND application for PBI-0451 - Pardes Biosciences announced that its Investigational New Drug, IND, application for PBI-0451 has been cleared by the United States Food and Drug Administration, FDA. "As we enter our third year of a global pandemic, we believe the value of oral direct-acting antivirals for SARS-CoV-2 has become increasingly clear, especially if they can be given as standalone therapies," said Uri A. Lopatin, M.D., Chief Executive Officer. "The clearance of our IND for PBI-0451 enables us to proceed with the initiation of additional Phase 1 clinical trials for PBI-0451 in the U.S. Pending additional engagement with FDA and other regulators, we anticipate initiating our global Phase 2/3 studies of PBI-0451 in SARS-CoV-2 infected patients in mid-2022."

07:03 EST Granite announces divestitures, share repurchase and strategic actions - Granite Construction announced several actions designed to position the company to focus on growing its core civil construction and materials business. The company has entered into a definitive agreement with Inland Pipe Rehabilitation, a portfolio company of investment affiliates of J.F. Lehman, to sell Inliner for a purchase price of $159.7M. The sale has been unanimously approved by the company's Board of Directors and is subject to customary covenants and closing conditions. The transaction is expected to close in the next two to four months. The company intends to divest the two remaining businesses within the Water and Mineral Services operating group, Water Resources and Mineral Services. As such, WMS will be considered held for sale and presented as discontinued operations as of December 31, 2021. The Board of Directors authorized an increase in the share repurchase program from $157M to $300M. The company reorganized its operating groups to improve operating efficiencies and better position the company for long-term growth in alignment with its new strategic plan. Its new operating groups are: California; Mountain, in Alaska, Nevada, Utah, and Washington; and Central, which primarily includes offices in Arizona, Colorado, Guam, Florida, Illinois and Texas. The new reportable segments will be: Construction and Materials.

06:57 EST Xylem raises quarterly dividend 7% to 30c per share - The dividend is payable on March 17 to shareholders of record as of February 17.

06:56 EST Quest Diagnostics CFO Mark Guinan to retire - Quest also announced that Mark Guinan, executive VP and CFO, has announced his intention to retire in 2022, following eight and a half years in the role. A process to identify Quest's new CFO has begun. Guinan will participate in the selection process and will remain in his role through the transition.

06:50 EST Advanced Drainage announces new $1B share repurchase plan

06:50 EST NuStar Energy sees 2022 EBITDA up 6% to $700M-$750M - NuStar Energy CEO Brad Barron said, "Turning to our full-year 2022 projections, we are encouraged by signs of continuing economic rebound, and we currently expect to generate full-year 2022 net income in the range of $242M-$270M, and EBITDA in the range of $700M-$750M, the midpoint of which represents 6% growth over our 2021 EBITDA, adjusted for the Eastern U.S. terminals sale and other items. With regard to strategic capital spending estimates, we plan to spend $135M-$165M this year. Of that total spending, we are allocating approximately $55Mto growing our Permian system, which is scalable with our producers' throughput volume needs, and about $25M to expand our West Coast Renewable Fuels Network. In addition, we expect to spend $35M-$45M on reliability capital this year. Once again, we expect to self-fund all of our 2022 spending from internally generated cash flows, just as we did in 2021, and we remain committed to continuing to improve our debt-to-EBITDA ratio in 2022," Barron concluded.

06:44 EST Equitrans Midstream issues statement on Mountain Valley Pipeline project - Equitrans Midstream issued the following statement regarding the Mountain Valley Pipeline - MVP - project: "On Wednesday, February 2, 2022, the U.S. Fourth Circuit Court of Appeals issued a decision vacating MVP's Biological Opinion and remanding it on specific issues. The Court's written decision was initially issued under seal, due to the potential identification of and reference to endangered species locations, and it is expected the seal will be lifted shortly. The MVP project team is taking time to thoroughly review the information outlined in the decision and is evaluating the project's next steps regarding the Biological Opinion. We remain committed to completing the MVP project and believe the concerns associated with MVP's Biological Opinion can be addressed by the agency".

06:39 EST Tradeweb Markets reports $22.3T total volume traded in January - Tradeweb Markets reported trading volume for January. Total trading volume for January was $22.3T. Average daily volume for the month was $1.12T, an increase of 7.6% year-over-year. In January, fully electronic share for U.S High Yield TRACE set a Tradeweb record of 8.2%. Additionally, Tradeweb set a new ADV record in European government bond trading.

06:36 EST Trane announces new $3B share repurchase plan - The Board of Directors authorized a new share repurchase program of up to $3B, to commence upon the completion of the company's 2021 $2B program. The 2021 program had approximately $1.05B remaining as of Jan 31, 2022.

06:33 EST Snap-On sees 2022 CapEx $90M-$100M - Sees 2022 effective income tax rate 23%-24%.

06:24 EST Nintendo cuts annual dividend to Y1,700 from Y2,220

06:18 EST Maxeon Solar announces new 40-year warranty for Back Contact product line - Maxeon Solar announced the launch of a combined warranty on its Maxeon Interdigitated Back Contact product line, which is sold in most countries outside the U.S. and Canada under the SunPower Maxeon brand. The new warranty covers product quality, power performance, and services in select markets for 40 years.

06:10 EST Kodiak Sciences completes enrollment in GLEAM, GLIMMER trials - Kodiak Sciences announced that it has completed enrollment in its GLEAM and GLIMMER Phase 3 clinical trials of KSI-301, Kodiak's anti-VEGF antibody biopolymer conjugate, in patients with diabetic macular edema.

06:09 EST Greenbrier announces $345M in new orders to start Q2 - Greenbrier reported new railcar orders for 6,300 units valued at $685M in Q1. These orders increased its backlog to 28,000 units valued at $3B. Greenbrier also announced new orders totaling 2,900 units valued at $345M received during December and January, the first two months of its Q2 that began on December 1, 2021.

06:05 EST Nokia commits $400M to NGP Capital's Fund V - Nokia announced its commitment to NGP Capital's Fund V, a new $400M venture fund that will focus on growth stage companies. The fund's emphasis on companies developing emerging 5G use cases for industrial and business transformation aligns closely with Nokia's technology vision and its efforts to maximize the value shift towards cloud. Aiming to establish new partnership opportunities, the fund will invest in private companies that generate financial returns and are relevant to Nokia. Target investments will be evaluated on product market fit, unit economics and technology leadership. In addition, companies will be assessed on key ESG metrics, to support progress from an environmental, social and governance perspective.

05:56 EST Veon announces intention to move group parent company to the United Kingdom - Veon announced its intention to move its group parent company to the United Kingdom, with the introduction of a newly formed UK incorporated public limited company as the top holding company of the Veon Group. It is expected that the new UK Parent company will replace Veon as the Veon Group's ultimate parent company by way of a Bermuda court-approved scheme of arrangement. The proposal represents a move away from incorporation in Bermuda to the United Kingdom. It is expected that such change will also provide the company with the necessary flexibility vis-a-vis current and future tightening of regulatory requirements in many of its markets of operation, including Russia, which recently introduced a new law introducing certain conditions for companies participating in Russian state and municipal procurement tenders or contracts. The company is not anticipating any adverse tax consequences as a result of this change. In addition, we do not anticipate any material changes to the Veon Group's corporate governance framework, including its existing board and committee structure.

05:42 EST Royal Dutch Shell announces $8.5B share buyback program - Shell announced the commencement of a share buyback program of $8.5B for the first half of 2022. This comprises the remaining $5.5B of Permian divestment proceeds and $3B as part of the company's capital allocation framework, which includes shareholder distributions in the range of 20%-30% of cash flow from operations. It is intended that, subject to market conditions, this program will be completed by the company's Q2 results, which are scheduled for July 28. In the first tranche of this buyback program, the company has entered into an irrevocable, non-discretionary arrangement with a broker to enable the purchase of ordinary shares for a period up to and including May 4. The aggregate maximum consideration for the purchase of ordinary shares under the initial program is $4B. The purpose of the initial program is to reduce the issued share capital of the company. All shares repurchased as part of this arrangement will be cancelled. The maximum number of ordinary shares which may be purchased by the company under the initial program is 622,094,828, which is the maximum pursuant to the authority granted by shareholders at the company's annual general meeting, less the number of ordinary shares that were repurchased by the company pursuant to the share buyback programs announced on July 29, 2021 and December 2, 2021.

05:33 EST Best Buy selects AWS as preferred cloud provider - Amazon (AMZN) announced that Best Buy (BBY) has selected AWS as its preferred cloud provider for cloud infrastructure services and its strategic partner for developing cloud engineering talent. This collaboration will help Best Buy further apply cloud technology across its retail operations and support the rapid innovation of its customer experiences and the work of its teams to create digital experiences that can enrich the lives of millions.

05:21 EST Intech announces management-led buyout from Janus Henderson Group - Intech and Janus Henderson Group announced that Intech's management team will acquire the company from Janus Henderson. The transaction is expected to close before the end of the first half of 2022. The financial terms of the transaction were not disclosed. Upon completion of the transaction, Intech will become a fully independent company. Intech will be 100% owned by the company's founder, employees, and board members. As part of the transaction, Intech will form a new board of directors chaired by Churchill Franklin, co-founder and former CEO of Acadian Asset Management. The new board will assume an active role in overseeing the company's go-forward strategy and all other aspects of the business.